C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology ( ESMO ) Congress 2024

2 weeks ago

Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity ...

Ticker	Sentiment	Impact
CCCC	Neutral	35 %